Second-generation antipsychotics

Second-generation antipsychotics are atypical psychiatric medications used in Abnormal Psychology to treat schizophrenia and bipolar disorder by affecting dopamine and serotonin. They often cause fewer movement side effects than older antipsychotics.

What are second-generation antipsychotics?

Second-generation antipsychotics are a class of psychiatric medications used in Abnormal Psychology to reduce psychosis and stabilize severe mood symptoms. You will also hear them called atypical antipsychotics.

These drugs are usually discussed when a course covers biological treatments for schizophrenia, bipolar disorder, and other disorders with hallucinations, delusions, or manic symptoms. They are not one single drug, but a group that includes medications such as clozapine, risperidone, and olanzapine.

What makes them “second-generation” is the way they work in the brain. Older antipsychotics mainly focused on dopamine receptors, especially D2 receptors. Second-generation antipsychotics still affect dopamine, but they also act on serotonin systems, which is why they can reduce psychotic symptoms while sometimes causing fewer extrapyramidal side effects, like tremors, stiffness, or restlessness.

That broader action is part of why these medications are often preferred in clinical settings. But “fewer side effects” does not mean “no side effects.” Weight gain, sleepiness, elevated blood sugar, and other metabolic changes are common concerns, so people taking them are usually monitored over time.

In a class case example, a person with schizophrenia who is having hallucinations might be prescribed a second-generation antipsychotic to reduce those symptoms and make daily functioning easier. A person with bipolar disorder might take one during mania or as part of longer-term management, depending on the treatment plan.

A useful way to think about this term is that it sits at the intersection of brain chemistry and symptom control. Abnormal Psychology uses it to show how clinicians try to treat serious mental disorders by changing neurotransmitter activity, while also balancing effectiveness against side effects.

Why second-generation antipsychotics matter in Abnormal Psychology

Second-generation antipsychotics matter because they are one of the main biological treatments discussed for psychotic disorders and some mood disorders in Abnormal Psychology. If you are reading a case description of hallucinations, delusions, mania, or disorganized thinking, this is one of the main medication classes you would expect to see.

The term also helps you compare treatment approaches. A lot of psychopharmacology questions are really asking whether you can connect a symptom pattern to the right kind of medication and then explain the trade-off between benefits and risks. With second-generation antipsychotics, that trade-off often looks like improved symptom control and a lower chance of movement-related side effects, but a higher need to watch for metabolic problems.

It also shows up in discussions of diagnosis and chronic care. Someone with schizophrenia may need ongoing medication management, regular follow-ups, and side-effect monitoring, so this term is not just about the pill itself. It connects to treatment planning, adherence, and how long-term care is described in case studies.

How second-generation antipsychotics connect across the course

Schizophrenia

Second-generation antipsychotics are commonly used to manage symptoms of schizophrenia, especially hallucinations and delusions. In a case study, the diagnosis helps explain why an antipsychotic is being prescribed in the first place. The medication does not cure schizophrenia, but it can lower symptom intensity and improve day-to-day functioning.

Bipolar Disorder

These medications are also used in bipolar disorder, especially when mania includes psychosis or severe agitation. That makes them different from treatments that focus only on depression or anxiety. In an essay or scenario, bipolar symptoms help you identify why a clinician might choose this drug class.

First-Generation Antipsychotics

This is the most common comparison point. First-generation antipsychotics mainly target dopamine and are more likely to cause extrapyramidal side effects, while second-generation drugs usually affect both dopamine and serotonin. If you see a question about side effects, this contrast is usually what the question is aiming at.

Dopamine D2 Receptors

Second-generation antipsychotics still interact with dopamine pathways, including D2 receptors, but they do so alongside serotonin effects. That matters because many psychosis symptoms are linked to dopamine activity. In a biology-based explanation, D2 receptor activity is part of the mechanism behind symptom reduction.

Are second-generation antipsychotics on the Abnormal Psychology exam?

A quiz item or case vignette usually asks you to identify the medication class from a symptom profile or from a side-effect description. If the prompt mentions hallucinations, delusions, mania, or a patient with schizophrenia taking risperidone, olanzapine, or clozapine, you would connect that to second-generation antipsychotics. If the question compares side effects, look for lower extrapyramidal symptoms but possible weight gain, sedation, or metabolic syndrome. In short-answer responses, name the class, state what it treats, and explain the dopamine-plus-serotonin mechanism in plain language. For discussion posts or essays, use it as an example of how biological treatments try to reduce symptoms without ignoring long-term monitoring.

Second-generation antipsychotics vs First-Generation Antipsychotics

These two are the main antipsychotic classes students mix up. First-generation antipsychotics are older drugs that focus more directly on dopamine and are more likely to cause movement-related side effects. Second-generation antipsychotics also affect serotonin, and that broader action often means fewer extrapyramidal symptoms, though they can still cause metabolic side effects.

Key things to remember about second-generation antipsychotics

• Second-generation antipsychotics are atypical medications used in Abnormal Psychology to treat symptoms of schizophrenia and bipolar disorder.

• They work by affecting both dopamine and serotonin systems, not just dopamine alone.

• They are often preferred over first-generation antipsychotics because they usually cause fewer movement-related side effects.

• They still require monitoring because weight gain, sedation, and metabolic changes can happen.

• When you see a case study with hallucinations, delusions, or mania, this is one of the main biological treatments to consider.

Frequently asked questions about second-generation antipsychotics

What is second-generation antipsychotics in Abnormal Psychology?

Second-generation antipsychotics are atypical psychiatric medications used to treat disorders like schizophrenia and bipolar disorder. They affect dopamine and serotonin pathways, which can reduce psychotic symptoms and mood instability. In Abnormal Psychology, they are a core example of biological treatment.

How are second-generation antipsychotics different from first-generation antipsychotics?

The biggest difference is the side-effect profile and receptor activity. First-generation antipsychotics mainly target dopamine and are more likely to cause extrapyramidal symptoms like tremors or stiffness. Second-generation antipsychotics also affect serotonin, and they usually cause fewer movement side effects but more metabolic concerns.

What disorders are second-generation antipsychotics used for?

They are commonly used for schizophrenia and bipolar disorder, especially when symptoms include psychosis or severe mania. Some medications in this class may also be used in other clinical situations, but those two disorders are the main ones you will see in Abnormal Psychology. The exact choice depends on the symptoms and side-effect risks.

What are common side effects of second-generation antipsychotics?

Common side effects include weight gain, sleepiness, and metabolic changes such as higher blood sugar or cholesterol. They are often chosen because they have a lower risk of movement-related side effects than older antipsychotics. Even so, patients usually need regular monitoring.